This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Nov;52(5):1297-9.

doi: 10.1016/j.eururo.2007.08.024. Epub 2007 Aug 21.

Role of hK2 in predicting clinically insignificant prostate cancer

Alberto Briganti

PMID: 17822837
DOI: 10.1016/j.eururo.2007.08.024

Editorial

Role of hK2 in predicting clinically insignificant prostate cancer

Alberto Briganti. Eur Urol. 2007 Nov.

. 2007 Nov;52(5):1297-9.

doi: 10.1016/j.eururo.2007.08.024. Epub 2007 Aug 21.

Author

Alberto Briganti

PMID: 17822837
DOI: 10.1016/j.eururo.2007.08.024

No abstract available

PubMed Disclaimer

Comment on

hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
Raaijmakers R, de Vries SH, Blijenberg BG, Wildhagen MF, Postma R, Bangma CH, Darte C, Schröder FH. Raaijmakers R, et al. Eur Urol. 2007 Nov;52(5):1358-64. doi: 10.1016/j.eururo.2007.04.037. Epub 2007 Apr 20. Eur Urol. 2007. PMID: 17499425 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information